STOCK TITAN

IBEX SEC Filings

IBEX NASDAQ
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

IBEX Ltd. asks shareholders to vote at its virtual 2026 annual meeting on December 10, 2026, on eight matters: setting a maximum of eight directors, electing eight nominees, allowing the Board to fill vacancies, advisory executive-pay votes, a Bye-law 74 amendment, an LTIP amendment, and auditor appointment. The Board recommends annual say-on-pay votes; the auditor proposal covers Deloitte & Touche LLP for the fiscal year ended June 30, 2027. Audited fiscal 2026 statements will be presented, without a shareholder approval vote.

The proposed LTIP amendment, subject to shareholder approval, would authorize 1,000,000 additional Common Shares and bring the aggregate reserve to 3,637,326.13 shares. As of October 9, 2026, 460,424 shares remained available under the current plan. The dilution table dated June 30, 2026 reports 10.6% potential basic dilution for available-plus-requested shares and 19.8% total potential basic dilution/overhang. The separate Bye-law proposal would replace the 75% amendment threshold with a simple majority, if approved by shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

IBEX Limited is asking shareholders to act at its December 10, 2026 annual general meeting. The agenda includes setting the board maximum at eight and electing eight nominees; authorizing the Board to fill vacancies; advisory votes on named executive compensation and vote frequency; a Bye-law amendment to replace the current 75% amendment threshold with a simple majority; an LTIP amendment; and appointment of Deloitte & Touche LLP as auditor for the fiscal year ended June 30, 2027. The record date is October 9, 2026.

The LTIP proposal, subject to shareholder approval, would add 1,000,000 Common Shares, bringing the plan’s aggregate reserve to 3,637,326 shares. The table reports 10.6% potential basic dilution from shares remaining available plus requested shares, and 19.8% total potential basic dilution/overhang. IBEX will present its audited fiscal 2026 financial statements at the meeting, but shareholders will not vote to approve them. The proposed say-on-pay and vote-frequency results are non-binding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
Rhea-AI Summary

IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal reported the disposition of 702 Common Shares on October 7, 2026, transferring them to a third party under a legal agreement related to a divorce dated December 29, 2025. The transfer was not discretionary. His directly held position after the transfer was 41,277 Common Shares. The reported $43.16 per-share figure was the issuer's closing price on October 7, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

IBEX Ltd Chief Technology Officer Michael Ringman acquired 9,038 common shares on September 30, 2026, when performance-based stock units were earned and converted into common shares. The issuer withheld 2,599 shares to satisfy tax liability upon vesting; the withholding was non-discretionary, and Ringman sold no shares for that purpose. The $43.26 figure was the common shares’ closing price on that date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal acquired 2,348 performance-based stock units on September 30, 2026, upon certification of performance goals for the two-year period ending June 30, 2026; the units converted to common shares. The issuer withheld 843 shares upon vesting to satisfy his tax liability. This was described as non-discretionary, and the reported $43.26 per-share amount was the common shares’ closing price that day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

IBEX Ltd Chief Operating Officer David Martin Afdahl acquired 3,228 common shares when performance-based stock units were earned and converted on September 30, 2026. The issuer withheld 1,590 shares to satisfy his tax liability upon vesting; the withholding was not discretionary, and Afdahl did not sell shares to satisfy the liability. The stated closing price was $43.26 per common share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

IBEX Ltd Chief Sales/Marketing Officer Julie K. Casteel earned 3,228 performance-based stock units (PSUs) on September 30, 2026; the units converted to common shares. On the same date, the issuer withheld 1,271 shares to satisfy her tax liability upon vesting. The footnote says the withholding was not discretionary and that Casteel did not sell shares to satisfy the liability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

At IBEX Ltd, Chief Sales and CS Officer Bruce Neil Dawson earned and acquired 3,228 performance-based stock units on September 30, 2026, after certification of performance goals for the two-year period ending June 30, 2026; the units converted to Common shares. The issuer withheld 1,413 shares upon vesting to satisfy Dawson's tax liability. The Common shares' closing price that day was $43.26. The withholding was not discretionary, and Dawson did not sell shares to satisfy the tax liability. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

IBEX Ltd Chief Executive Officer Robert Thomas Dechant earned and acquired 14,524 performance-based stock units (PSUs) on September 30, 2026, after certification of performance goals for the two-year period ending June 30, 2026; the PSUs converted to common shares. On the same date, IBEX withheld 6,587 shares upon vesting to satisfy Dechant’s tax liability. The withholding was not discretionary, and Dechant did not sell shares to satisfy the liability. The reported $43.26 per-share figure was the closing price that day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many IBEX (IBEX) SEC filings are available on StockTitan?

StockTitan tracks 157 SEC filings for IBEX (IBEX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for IBEX (IBEX)?

The most recent SEC filing for IBEX (IBEX) was filed on October 28, 2026.